NCT03638908View on ClinicalTrials.gov

Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2017

Study Completion Date

December 31, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Fluoxetine

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03638908 - Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial | Biotech Hunter | Biotech Hunter